Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
32.88
-0.21 (-0.63%)
At close: Jun 26, 2025, 4:00 PM
32.88
0.00 (0.00%)
After-hours: Jun 26, 2025, 4:04 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.24 billion as of June 26, 2025. Its market cap has decreased by -45.06% in one year.
Market Cap
4.24B
Enterprise Value
2.66B
1-Year Change
-45.06%
Ranking
Category
Stock Price
$32.88
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.24B, an increase of 207.37%. That is a compound annual growth rate of 25.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2025 | 4.27B | -58.16% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |